Covid, Health

Nasal Vaccine iNCOVACC For COVID-19: Know How It Works, Benefits, And Side Effects


iNCOVACC: What Is It?

The world’s first active nasal vaccine against Coronavirus infection is called iNCOVACC. It is a SARSCoV-2 vaccine based on an adenoviral vector that can only be given through the nose.

Key Features:

  • A robust immune response is triggered by an intranasal vaccine, and it works to neutralize IgG, mucosal IgA, and T-cell responses.
  • Due to the nasal mucosa’s well-established immune system, the nasal passage has impressive potential for vaccines. It is non-invasive and painless. It is easy to administer and does not require trained professionals. There is no risk of needle-related injuries or infections. Effective compliance supports meeting global demand.

Who Can Receive The Nasal Vaccine?

The Indian government has supported Bharat Biotech’s intranasal immunization, iNCOVACC, for adults over 18 years of age. Adults who have already taken two doses of either Covishield or Covaxin can also take it as a booster.

Who should not obtain iNCOVACC?

You shouldn’t accept iNCOVACC if you:

  • Allergies to any of the vaccine’s components.
  • Previous reactions to this vaccine were severe.
  • Fever or acute infection.

How is the vaccine given through the nose?

The nasal administration of iNCOVACC requires two doses to be taken within four weeks of the first. Each nostril receives four drops of the medication, for a total of eight drops (0.5 milliliters).

Before receiving iNCOVACC, what information should a person provide to the healthcare provider?

Your medication history should be disclosed to the supervisor, including:

  • If you are immunocompromised, are you taking medication that affects your immune system?
  • If you are pregnant, have you had another COVID shot?
  • If you are on regular medication for any medical condition, what is the duration of those medications, and for which health condition?
  • If you have allergies or a fever;
  • If you are on a blood thinner or have a bleeding disorder.

What advantages does iNCOVACC offer?

There have been a lot of trials on the iNCOVACC nasal vaccine. In phase 3 clinical study with 3,000 participants, two doses taken four weeks apart produced high immunity. But it’s critical to remember that getting the vaccine doesn’t mean you shouldn’t take other precautions if you get Coronavirus.

How does the iNCOVACC COVID-19 vaccine affect the body?

The following side effects have been observed thus far:

  • After receiving a nasal vaccine, a mild allergic reaction may occasionally occur, such as headache, fever, runny nose, or sneezing. iNCOVACC did not record any such incidents during the study period.

What should I do if something goes wrong?

If you experience any side effects, you should contact or visit your medical care provider or the official administering the immunization or go to an emergency clinic. Additionally, the manufacturer of iNCOVACC, Bharat Biotech International Limited, can be contacted 24 hours a day, seven days a week via a toll-free number to report any side effects following vaccination: 1800 102 2245.

Where can I get the iNCOVACC vaccination?

All private hospitals now offer the nasal vaccine. Beginning on December 23, 2022, individuals will be able to make online appointments for COVID iNCOVACC booster doses through the Cowin app.

How much does iNCOVACC cost in India?

In private hospitals, the iNCOVACC vaccine costs Rs 800 for each dose. It will initially be available in private hospitals as a heterologous booster dose. However, government officials have said it will also be part of the vaccination program.

Helpful: New Omicron Subvariant BF.7: Know About Its Symptoms And Severity


Do I have a choice about which vaccine I get?

Yes, the Co-WIN portal lists the vaccines that are available at COVID Vaccination Centers, both public and private, according to age-appropriate criteria. The beneficiary has the option of receiving a specific vaccine at a CVC of their choice.

Is COVISHIELD comparable to the vaccine administered by AstraZeneca in the United Kingdom?

The Serum Institute of India’s Covishield vaccine is based on the same patent technology as the AstraZeneca vaccine used in other countries.

Related Posts

Leave a Reply